Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07894289Phase 1Not yet recruiting
Phase 1, randomised trial of ethanol (2 arms), sponsored by The Ohio State University. Primary endpoints: Startle eyeblink potentiation during the threat task at 14 days, Subjective affective response to alcohol in the lab and 3 more. Planned start Dec 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07894289.